Is there a possibility for individuals recuperating from dengue fever to acquire immunity towards COVID-19?
The Research of Professor Miguel Nicolelis Becomes a Talking Point
In an intriguing find by Almaty.tv, Reported by Ren TV, Duke University's Professor Miguel Nicolelis suggests a captivating theory: people who've battled dengue fever may carry some immunity to the coronavirus.
Some experts, however, aren't convinced. According to Daily Mail, in his study, Nicolelis compared the spread of coronavirus and dengue fever geographically. He noted that areas with lower infection rates and slower disease progression were also places that had experienced intense dengue outbreaks.
"This shocking discovery hints at a fascinating possibility of immunological cross-reactivity between dengue serotypes and SARS-CoV-2," professes the scientist.
If this theory holds water, it could mean that a past dengue fever infection or vaccination could potentially offer some shield against COVID-19. However, doctors interviewed by Gazeta.Ru refuted this claim, attributing the low number of COVID-19 cases in these regions to socio-economic factors and the diseases that these populations commonly contract.
Alexander Lukashov, the director of the Institute of Medical Parasitology, Tropical and Transmitted Diseases at Sechenov University, agrees. Lukashov states, "They are more different than we are from E. coli. Thus, the probability that these are cross-reactive antibodies, i.e., those produced in response to one infection and acting on another, is incredibly low."
However, it's important to note that current evidence suggests that the immune mechanisms for dengue and COVID-19 are distinct, with socio-economic factors likely playing a secondary yet significant role in observed epidemiological patterns. The absence of studies linking dengue antibodies to protection against SARS-CoV-2 in the reviewed literature indicates that Professor Nicolelis's hypothesis remains unsupported by peer-reviewed data.
Insights from Additional Research- Vitamin D's immunomodulatory role is a common factor in both dengue and COVID-19, helping regulate critical inflammatory responses. - Despite this, no direct cross-protective immunity between dengue and COVID-19 has been identified in the reviewed studies.- Dengue immunity is serotype-specific and offers only temporary protection against other dengue serotypes.- No HLA-linked protection against COVID-19 has been indicated based on thealleles that may reduce susceptibility to severe dengue.- Socio-economic factors significantly influence infectious disease spread and severity. Vaccine accessibility, among other factors, can impact disease outcomes.
Enrichment data drawn from various sources, but used sparingly to enrich the article rather than overshadowing the base article.
- Recent research in environmental science and medical-conditions has unveiled a potential link between Vitamin D and immunomodulatory roles in both coronavirus and dengue.
- Regarding the hypothesis proposed by Professor Miguel Nicolelis, limited evidence currently supports direct cross-protective immunity between dengue and coronavirus.
- In the realm of dengue immunity, it is known to be serotype-specific, providing only temporary protection against other dengue serotypes.
- Contrary to Professor Nicolelis's theory, no HLA-linked protection against COVID-19 has been indicated based on alleles that may reduce susceptibility to severe dengue.
- Socio-economic factors such as vaccine accessibility play a significant role in shaping the spread and severity of infectious diseases like dengue and COVID-19.
- As technology advances, it is crucial for the cybersecurity industry to secure data relating to health-and-wellness, climate-change, and environmental-science, to maintain the integrity of research findings.
- In light of ongoing research, CBD, a natural component often used in health-and-wellness products, may hold possibilities for future studies in understanding and managing inflammatory responses related to dengue and coronavirus.
